Fate Therapeutics Announces Day 100 Clinical Results from Phase 1 Stage of PROTECT Trial of ProTmune™ and …  Markets InsiderFull coverage http://markets.businessinsider.com/news/stocks/Fate-Therapeutics-Announces-Day-100-Clinical-Results-from-Phase-1-Stage-of-PROTECT-Trial-of-ProTmune-and-Initiation-of-Phase-2-Stage-1011000007

Advertisements